As anticipated, the serum levels of EA-IgA, Rta-IgG, VCA-IgA and P85-Ab were substantially lower in these patients than in those with NPC, which validated the specificity of these four serum markers for NPC. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.